Thomas Kaufmann has 13 years of experience in the financial industry. For over 10 years, he was Pharma/Biotech analyst for Credit Suisse Private Banking and later for the Investment Banking division. He was also responsible for the megatrend innovation. Before joining Kieger AG, he worked for a Swiss Biotech company active in the area of oncology.
Thomas Kaufmann studied biochemistry and did his PhD in biophysics (structural biology) at the Biozentrum of the University of Basel.